A review of the current understanding and clinical utility of miRNAs in esophageal cancer
- PMID: 24013023
- DOI: 10.1016/j.semcancer.2013.08.005
VSports - A review of the current understanding and clinical utility of miRNAs in esophageal cancer
Abstract
Background: MicroRNAs (miRNAs) are a class of small, well-conserved, non-coding RNAs that regulate the translation of RNAs. They have a role in biological and pathological process including cell differentiation, apoptosis, proliferation and metabolism. Since their discovery, they have been shown to have a potential role in cancer pathogenesis through their function as oncogenes or tumor suppressors. A substantial number of miRNAs show differential expression in esophageal cancer tissues, and so have been investigated for possible use in diagnosis. Furthermore, there is increasing interest in their use as prognostic markers and determining treatment response, as well as identifying their downstream targets and understanding their mode of action. VSports手机版.
Methods: We analyzed the most recent studies on miRNAs in esophageal cancer and/or Barrett's esophagus (BE). The publications were identified by searching in PuBMed for the following terms: Barrett's esophagus and microRNA; esophageal cancer and microRNA V体育安卓版. .
Results: Four miRNAs (mi-R-25, -99a, -133a and -133b) showed good potential as diagnostic markers and interestingly five (mi-R-21, -27b, -126, - 143 and -145) appeared to be useful both as diagnostic and prognostic/predictive markers. V体育ios版.
Conclusion: The data so far on miRNAs in esophageal carcinogenesis is promising but further work is required to determine whether miRNAs can be used as biomarkers, not only in the clinical setting or added to individualized treatment regimes but also in non-invasive test by making use of miRNAs identified in blood. VSports最新版本.
Keywords: 5-FU; 5-fluorouracil; B cell lymphoma 2; BE; Barrett's esophagus; Bcl-2; Biomarkers; CD47; CDH1; Cluster of differentiation 47; DGCR8; DICER1; Diagnosis; E-Cadherin; EAC; ESCC; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; F box/WD repeat containing protein 7; FBXW7; FSCN1; HGD; High grade dysplasia; IGF1R; IRS; Insulin like growth factor receptor 1; LATS2; LDHB; LGD; LNM; Low grade dysplasia; Lymph node metastasis; MDR1; MISH; MicroRNA; MicroRNA [ribonucleic acid]; NE; Normal epithelium; Oesophageal cancer; P27; PPP2R1B; Pasha protein; Prognosis; Protein 53; Quantitative reverse transcription polymerase chain reaction; RNA; RNASEN; Rap1a; Rap1b; Ras related protein 1a; Ras related protein 1b; Ribonuclease 3 enzyme gene; ascin homolog 1, actin bundling protein; endoribonuclease of RNase III family; inflammatory risk score; lactate dehydrogenase B; large tumor suppressor, homolog 2; miRNA in situ hybridization; miRNA/miR; multi drug resistance 1; p53; protein 27; protein phosphatase 2 regulatory subunit beta isoform; qRT-PCR; ribonucleic acid. V体育平台登录.
Copyright © 2013. Published by Elsevier Ltd. VSports注册入口.
Publication types
- V体育安卓版 - Actions
MeSH terms
- "VSports最新版本" Actions
- "VSports" Actions
- VSports手机版 - Actions
- "V体育2025版" Actions
- "V体育平台登录" Actions
- "V体育2025版" Actions
- V体育官网入口 - Actions
Substances
Grants and funding
LinkOut - more resources
"VSports" Full Text Sources
"V体育平台登录" Other Literature Sources
Medical
Research Materials
Miscellaneous